Monoaminergic neuropathology in Alzheimer's disease

G Šimić, MB Leko, S Wray, CR Harrington… - Progress in …, 2017 - Elsevier
None of the proposed mechanisms of Alzheimer's disease (AD) fully explains the distribution
patterns of the neuropathological changes at the cellular and regional levels, and their …

[HTML][HTML] Lewy bodies, iron, inflammation and neuromelanin: pathological aspects underlying Parkinson's disease

P Riederer, T Nagatsu, MBH Youdim, M Wulf… - Journal of Neural …, 2023 - Springer
Since the description of some peculiar symptoms by James Parkinson in 1817, attempts
have been made to define its cause or at least to enlighten the pathology of “Parkinson's …

[HTML][HTML] Exosomes derived from bone-marrow mesenchymal stem cells alleviate cognitive decline in AD-like mice by improving BDNF-related neuropathology

S Liu, M Fan, JX Xu, LJ Yang, CC Qi, QR Xia… - Journal of …, 2022 - Springer
Background Alzheimer's disease (AD) is a neurodegenerative disease characterized by a
progressive decline in cognitive ability. Exosomes derived from bone-marrow mesenchymal …

Type 2 diabetes, cognition, and dementia in older adults: toward a precision health approach

B Cholerton, LD Baker, TJ Montine… - Diabetes Spectrum, 2016 - Am Diabetes Assoc
IN BRIEF There has been a concurrent dramatic rise in type 2 diabetes and dementia in the
United States, and type 2 diabetes shares common genetic and environmental risk factors …

Intracerebroventricular streptozotocin as a model of Alzheimer's disease: neurochemical and behavioral characterization in mice

KG Ravelli, BA Rosário, R Camarini… - Neurotoxicity …, 2017 - Springer
Streptozotocin has been widely used to mimic some aspects of Alzheimer's disease (AD).
However, especially in mice, several characteristics involved in the streptozotocin (STZ) …

Intranasal metformin treatment ameliorates cognitive functions via insulin signaling pathway in ICV-STZ-induced mice model of Alzheimer's disease

I Kazkayasi, G Telli, E Nemutlu, S Uma - Life Sciences, 2022 - Elsevier
Aims The relationship between type 2 diabetes and Alzheimer's disease (AD) provides
evidence that insulin and insulin sensitizers may be beneficial for the treatment of AD. The …

The diabetic brain and cognition

P Riederer, AD Korczyn, SS Ali, O Bajenaru… - Journal of neural …, 2017 - Springer
The prevalence of both Alzheimer's disease (AD) and vascular dementia (VaD) is increasing
with the aging of the population. Studies from the last several years have shown that people …

Anthocyanins as a potential pharmacological agent to manage memory deficit, oxidative stress and alterations in ion pump activity induced by experimental sporadic …

SM Pacheco, MSP Soares, JM Gutierres… - The Journal of …, 2018 - Elsevier
Anthocyanins (ANT) are polyphenolic flavonoids with antioxidant and neuroprotective
properties. This study evaluated the effect of ANT treatment on cognitive performance and …

Animal model of Alzheimer's disease induced by streptozotocin: New insights about cholinergic pathway

SSL Silva, LV Tureck, LC Souza, JV Mello-Hortega… - Brain research, 2023 - Elsevier
Alzheimer's disease (AD) is of multifactorial origin, and still presents several gaps regarding
its development and progression. Disorders of the cholinergic system are well known to be …

Evidence of disturbed insulin signaling in animal models of Alzheimer's disease

SS Alves, G Servilha-Menezes, L Rossi… - Neuroscience & …, 2023 - Elsevier
Since glucose reuptake by neurons is mostly independent of insulin, it has been an
intriguing question whether insulin has or not any roles in the brain. Consequently, the …